Company Filing History:
1 out of 832,761 Years Active: 2017
Title: **Jolene Windle: Innovating Cancer Diagnostics and Therapeutics**
Introduction
Jolene Windle, a prominent inventor based in Richmond, VA, has made significant contributions to the field of cancer research through her innovative work. With one patent to her name, she is recognized for her dedication to improving cancer diagnostics and therapeutics.
Latest Patents
Jolene is the inventor of the patent titled "Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics." This groundbreaking patent involves recombinant vectors that utilize a truncated CCN1 cancer selective promoter (tCCN1-Prom) to drive the expression of various elements, such as genes necessary for viral replication, detectable imaging agents, and therapeutic agents. These vectors hold the potential for substantial advancements in cancer therapy and diagnostics. Furthermore, the work includes transgenic animals that aid in the monitoring of cancer progression and are utilized in screening assays.
Career Highlights
Throughout her career, Jolene Windle has focused on creating innovative solutions that address critical challenges in cancer treatment and diagnostics. Her research demonstrates her commitment to understanding cancer biology and translating that knowledge into practical tools for improved patient care.
Collaborations
Jolene collaborates with other distinguished professionals in the field, including Paul B. Fisher and Swadesh K. Das. These partnerships enrich her research and facilitate the exchange of ideas and techniques, further enhancing the impact of her work on cancer research.
Conclusion
As a forward-thinking inventor, Jolene Windle stands out in the scientific community with her innovative approach to cancer diagnostics and therapeutics. Her patent reflects a significant step forward in the understanding and treatment of cancer, demonstrating her role as a vital contributor to the field. With ongoing collaborations and a commitment to research, Jolene continues to pave the way for future innovations in healthcare.